Ricstar,
OZL didn't miss out on acquiring Carrapateena, and their progress presentation today shows that they are moving ahead systematically with the necessary actions to bring it to production.
The AFR had an article about OZL today, and mentioned the very strong financial discipline that TB is maintaining.
I am currently happy with OZL management (not with the share price).